Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Nova Eye Medical Ltd
ASX:EYE

Watchlist Manager
Nova Eye Medical Ltd Logo
Nova Eye Medical Ltd
ASX:EYE
Watchlist
Price: 0.165 AUD Market Closed
Market Cap: AU$47m
Write Note Create Alert Ask AI

Profitability Summary

Nova Eye Medical Ltd's profitability score is 22/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

22/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

22/100
Profitability
Score
22/100
Profitability
Score

Margins

Earnings Waterfall
Nova Eye Medical Ltd

Margins Comparison
Nova Eye Medical Ltd Competitors

Country Company Market Cap Gross
Margin 		Operating
Margin 		Net
Margin
AU
Nova Eye Medical Ltd
ASX:EYE
46.9m AUD
Loading...
Loading...
Loading...
US
Abbott Laboratories
NYSE:ABT
195.4B USD
Loading...
Loading...
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
172.4B USD
Loading...
Loading...
Loading...
US
Stryker Corp
NYSE:SYK
140B USD
Loading...
Loading...
Loading...
IE
Medtronic PLC
NYSE:MDT
127.3B USD
Loading...
Loading...
Loading...
US
Boston Scientific Corp
NYSE:BSX
110.9B USD
Loading...
Loading...
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
45.8B EUR
Loading...
Loading...
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
50.2B USD
Loading...
Loading...
Loading...
US
Becton Dickinson and Co
NYSE:BDX
50.5B USD
Loading...
Loading...
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
44.4B USD
Loading...
Loading...
Loading...
US
Resmed Inc
NYSE:RMD
36.6B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Nova Eye Medical Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
AU
Nova Eye Medical Ltd
ASX:EYE
46.9m AUD
Loading...
Loading...
Loading...
Loading...
US
Abbott Laboratories
NYSE:ABT
195.4B USD
Loading...
Loading...
Loading...
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
172.4B USD
Loading...
Loading...
Loading...
Loading...
US
Stryker Corp
NYSE:SYK
140B USD
Loading...
Loading...
Loading...
Loading...
IE
Medtronic PLC
NYSE:MDT
127.3B USD
Loading...
Loading...
Loading...
Loading...
US
Boston Scientific Corp
NYSE:BSX
110.9B USD
Loading...
Loading...
Loading...
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
45.8B EUR
Loading...
Loading...
Loading...
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
50.2B USD
Loading...
Loading...
Loading...
Loading...
US
Becton Dickinson and Co
NYSE:BDX
50.5B USD
Loading...
Loading...
Loading...
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
44.4B USD
Loading...
Loading...
Loading...
Loading...
US
Resmed Inc
NYSE:RMD
36.6B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Nova Eye Medical Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

See Also

Summary
EYE intrinsic value, competitors valuation, and company profile.
DCF Valuation
EYE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EYE stock valuation using valuation multiples.
Wall Street Estimates
EYE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EYE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 317,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.